APA aipamena

Park, K., Hong, Y. S., Choi, J., Yoon, S., Kang, J., Kim, D., . . . Park, S. R. (2018). HSP90 inhibitor, AUY922, debilitates intrinsic and acquired lapatinib-resistant HER2-positive gastric cancer cells. BMB Rep.

Chicago Style aipamena

Park, Kang-Seo, et al. "HSP90 Inhibitor, AUY922, Debilitates Intrinsic and Acquired Lapatinib-resistant HER2-positive Gastric Cancer Cells." BMB Rep 2018.

MLA aipamena

Park, Kang-Seo, et al. "HSP90 Inhibitor, AUY922, Debilitates Intrinsic and Acquired Lapatinib-resistant HER2-positive Gastric Cancer Cells." BMB Rep 2018.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.